<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=Generator content="Microsoft Word 12 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Courier;
	panose-1:2 7 4 9 2 2 5 2 4 4;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
h1
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Courier New";}
h3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Courier New";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.XNotesHeading, li.XNotesHeading, div.XNotesHeading
	{mso-style-name:XNotesHeading;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	font-size:12.0pt;
	font-family:"Courier New";
	font-weight:bold;}
p.XNotes, li.XNotes, div.XNotes
	{mso-style-name:XNotes;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.Constitution, li.Constitution, div.Constitution
	{mso-style-name:Constitution;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.1Paragraph, li.1Paragraph, div.1Paragraph
	{mso-style-name:"\(1\)Paragraph";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-indent:-1.0in;
	font-size:12.0pt;
	font-family:"Courier New";}
p.aSubsection, li.aSubsection, div.aSubsection
	{mso-style-name:"\(a\)Subsection";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.ASubparagraph, li.ASubparagraph, div.ASubparagraph
	{mso-style-name:"\(A\)Subparagraph";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.5in;
	margin-bottom:.0001pt;
	text-indent:-1.5in;
	font-size:12.0pt;
	font-family:"Courier New";}
p.iClause, li.iClause, div.iClause
	{mso-style-name:"\(i\)Clause";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-indent:-2.0in;
	font-size:12.0pt;
	font-family:"Courier New";}
p.ASubparagraphContd, li.ASubparagraphContd, div.ASubparagraphContd
	{mso-style-name:"\(A\)SubparagraphContd";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.5in;
	margin-bottom:.0001pt;
	text-indent:-1.5in;
	line-height:200%;
	font-size:12.0pt;
	font-family:"Courier New";}
p.1ParagraphContd, li.1ParagraphContd, div.1ParagraphContd
	{mso-style-name:"\(1\)ParagraphContd";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:1.0in;
	margin-bottom:.0001pt;
	text-indent:-1.0in;
	line-height:200%;
	font-size:12.0pt;
	font-family:"Courier New";}
p.RegularParagraphs, li.RegularParagraphs, div.RegularParagraphs
	{mso-style-name:"\#Regular Paragraphs";
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	margin:0in;
	margin-bottom:.0001pt;
	font-size:12.0pt;
	font-family:"Courier New";}
 /* Page Definitions */
 @page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.0in 1.0in 1.0in;}
div.Section1
	{page:Section1;}
-->
</style>

</head>

<body lang=EN-US>

<div class=Section1>

<p class=RegularParagraphs>     <b>§329-22  Schedule V.</b>  (a)  The
controlled substances listed in this section are included in schedule V.</p>

<p class=RegularParagraphs><span style='letter-spacing:-.15pt'>     (b) 
Narcotic drugs containing nonnarcotic active medicinal ingredients.  Any
compound, mixture, or preparation containing limited quantities of any of the
following narcotic drugs, which also contains one or more nonnarcotic active
medicinal ingredients in sufficient proportion to confer upon the compound,
mixture, or preparation, valuable medicinal qualities other than those
possessed by the narcotic drug alone:</span></p>

<p class=1Paragraph>     (1)  Not more than 200 milligrams of codeine, or any
of its salts, per 100 milliliters or per 100 grams;</p>

<p class=1Paragraph><span style='letter-spacing:-.15pt'>     (2)  Not more than
100 milligrams of dihydrocodeine, or any of its salts, per 100 milliliters or
per 100 grams;</span></p>

<p class=1Paragraph><span style='letter-spacing:-.15pt'>     (3)  Not more than
100 milligrams of ethylmorphine, or any of its salts, per 100 milliliters or
per 100 grams;</span></p>

<p class=1Paragraph><span style='letter-spacing:-.15pt'>     (4)  Not more than
2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine
sulfate per dosage unit;</span></p>

<p class=1Paragraph><span style='letter-spacing:-.15pt'>     (5)  Not more than
100 milligrams of opium per 100 milliliters or per 100 grams; and</span></p>

<p class=1Paragraph><span style='letter-spacing:-.15pt'>     (6)  Not more than
0.5 milligram of difenoxin and not less than 25 micrograms of atropine sulfate
per dosage unit. </span></p>

<p class=RegularParagraphs>     <span style='letter-spacing:-.15pt'>(c)  </span>Stimulants. 
Unless specifically exempted or excluded or unless listed in another schedule,
any material, compound, mixture, or preparation that contains any quantity of
the following substances having a stimulant effect on the central nervous
system, including its salts, isomers, and salts of isomers.</p>

<p class=RegularParagraphs><span style='letter-spacing:-.15pt'>     </span>(d)  Depressants.
 Unless specifically exempted or excluded or unless listed in another schedule,
any material, compound, mixture, or preparation that contains any quantity of
the following substances having a depressant effect on the central nervous
system, including its salts, isomers, and salts of isomers:</p>

<p class=1Paragraph>     (1)  Lacosamide
[(R)-2-acetoamido-N-benzyl-3-methoxy-propionamide], (Vimpat); and</p>

<p class=1Paragraph>     (2)  Pregabalin [(S)-3-(aminomethyl)-5-methylhexanoic
acid]. [L 1972, c 10, pt of §1; am L 1978, c 68, §6; am L 1985, c 150, §4; am L
2003, c 151, §6; am L 2008, c 119, §6; am L 2010, c 123, §4]</p>

<p class=RegularParagraphs>&nbsp;</p>

<p class=RegularParagraphs>&nbsp;</p>

</div>

</body>

</html>
<center><table border="0" width="90%"><tr>
<td align="left"><a href="/hrscurrent/Vol06_Ch0321-0344/HRS0329/HRS_0329-0021.htm">Previous</a></td>
<td align="center"><a href=/hrscurrent/Vol06_Ch0321-0344>Vol06_Ch0321-0344</a></td>
<td align="right"><a href="/hrscurrent/Vol06_Ch0321-0344/HRS0329/HRS_0329-0023.htm">Next</a></td>
</tr></table></center>
